Streetbeat News

Earnings

TRVI

Trevi Therapeutics (NASDAQ:TRVI) reported Q4 earnings, beating estimated earnings by 11.0% with an EPS of $-0.08 versus an estimate of $-0.09. However, revenue was unchanged from the same period last year. In the previous quarter, the company also beat EPS estimates, which was followed by a 3.0% drop in share price the next day.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 8:20 pm

TRVI

Trevi Therapeutics reported Q4 2023 GAAP EPS of $(0.08), surpassing the analyst consensus estimate of $(0.09) by 11.11%.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:19 pm

MU

Micron Technology Inc (NASDAQ:MU) reported fiscal Q2 earnings with revenue of $5.82 billion and adjusted EPS of 42 cents, surpassing analyst estimates. The company has beaten estimates for four consecutive quarters and expects Q3 revenue of $6.6 billion. Micron's strong performance and positive outlook, particularly in AI, drove its shares up 11.7% after hours.

Portfolio Pulse from Adam Eckert

March 20, 2024 | 8:19 pm

GES

Guess (NYSE:GES) reported Q4 earnings of $2.01 per share, surpassing the $1.56 estimate, marking a 28.85% beat and a 15.52% increase from last year. Sales reached $891.05M, exceeding the $855.54M estimate by 4.15% and showing an 8.96% increase from the previous year.

Portfolio Pulse from dijoy@benzinga.com

March 20, 2024 | 8:18 pm

ALVO

Alvotech reported FY 2023 GAAP EPS of $(2.43), missing the $(1.07) estimate, and sales of $93.4M, below the $112.47M estimate.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:18 pm

OABI

OmniAb (NASDAQ:OABI) reported Q4 2023 earnings with a GAAP EPS of $(0.14), surpassing the $(0.15) estimate. However, its sales of $4.822M fell short of the $7.467M estimate, marking an 86.36% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:17 pm

HLVX

HilleVax reported a Q4 2023 GAAP EPS of $(0.78), surpassing the analyst consensus estimate of $(0.83) by 6.02%.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:16 pm

FIVE

Five Below (NASDAQ:FIVE) reported Q4 earnings with an EPS of $3.65, missing estimates by -3.0% against an expected $3.78. Revenue increased by $215.20 million year-over-year. In the previous quarter, FIVE slightly beat EPS estimates and saw no change in share price the following day.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 8:15 pm

SCS

Steelcase (NYSE:SCS) reported Q4 earnings with an EPS of $0.23, beating estimates by 10.0% but with a revenue decrease of $26.50 million from the previous year. The company had previously beaten EPS estimates last quarter, leading to an 11.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 8:15 pm

BEAT

HeartBeam (NASDAQ:BEAT) reported its Q4 earnings with an EPS of $-0.13, matching the estimated earnings. However, revenue did not show growth compared to the same period last year. Following a similar earnings miss last quarter, the share price dropped by 10.0% the next day.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 8:15 pm